Health Care & Hospitals

Pharmaceutical packaging market size to grow by USD 48.88 billion from 2022 to 2027, The rise in R&D spending in the pharmaceutical industry to drive the market growth

by

NEW YORK, Nov. 5, 2023 /PRNewswire/ — The global pharmaceutical packaging market size is estimated to grow by USD 48.88 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 8.44%. The rise in R&D spending in the pharmaceutical industry is driving market growth. Pharmaceutical companies are investing heavily in … Read more

Ironside HR, No. 7 on the 2023 SMU D100 List

by

DALLAS, Nov. 3, 2023 /PRNewswire/ — Ironside Human Resources was named as Placeholder No. 7 last night during the Annual Dallas 100 Entrepreneur Awards Gala hosted by the SMU Cox School of Business. The gala took place at the Hyatt Regency in Dallas. Representatives from each of the recognized companies were present at the event. … Read more

Rising Demand for Value-Based Care Propels Growth in Healthcare Operational Analytics Market

by

DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Healthcare Operational Analytics Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to  ResearchAndMarkets.com’s offering. The global healthcare operational analytics market, estimated at USD 10.7 billion in 2022, is on track to achieve remarkable growth, projected to reach USD 22.4 … Read more

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

by

Updated data from the Phase I trial of RVU120 in relapsed/refractory acute myeloid leukemia (r/r AML) or high-risk myelodysplastic syndromes (HR-MDS) demonstrate clinically relevant benefit in 50% of evaluable patients Preclinical data support RVU120 as a novel agent for the treatment of patients with lower-risk MDS (LR-MDS) and show cytotoxic and differentiating effects on leukemic stem cells … Read more

Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences

by

DUBLIN, Nov. 1, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference on Tuesday, November 14, 2023 Fireside chat at 4:30 a.m. PT / 7:30 a.m. ET / 12:30 p.m. GMT 6th Annual Evercore ISI HealthCONx Conference on Tuesday, … Read more

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market

by

DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Recombinant DNA Technology: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Recombinant DNA Technology estimated at US$64.7 Billion in the year 2022, is projected to reach a revised size of US$93.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period … Read more

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

by

Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery system  Phase 1 results show a manageable safety profile with limited systemic toxicity, and early complete responses in patients with high-risk and intermediate-risk NMIBC MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & … Read more

New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer

by

Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and simultaneously published in The New England Journal of Medicine MADRID, Oct. 21, 2023 /PRNewswire/ — … Read more

AMA president Ehrenfeld to address looming physician shortage at a National Press Club Newsmaker on Oct. 25

by

WASHINGTON, Oct. 20, 2023 /PRNewswire/ — On Wednesday, Oct. 25 at 1 p.m. the American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, will address what America’s looming physician shortage means for patients and health care, and how to fix it at an NPC Newsmaker. Jesse M. Ehrenfeld, MD, MPH, was inaugurated as president … Read more

excellent medtech research cluster and innovative companies

by

Saxony-Anhalt is a pioneer in medical technology – as proven on a daily basis by the 120 companies in this sector who have set up in the area. Here, they benefit from an extensive research and science landscape and networking in clusters. The close interaction between business and academia gives rise to innovations across the … Read more